TABLE 5.
Pretransplant SCA-based categoriesa (n = 180) | 3-Mo posttransplantb (n = 118) | 6-Mo posttransplantb (n = 140) | Total pre-LT | ||||
---|---|---|---|---|---|---|---|
Good | Fair | Poor | Good | Fair | Poor | ||
Good | 63 (63%) | 4 (4%) | 0 | 76 (76%) | 5 (5%) | 1 (1%) | 100 (56%) |
Fair | 34 (56%) | 4 (7%) | 1 (2%) | 39 (64%) | 6 (10%) | 0 | 61 (34%) |
Poor | 9 (47%) | 3 (16%) | 0 | 9 (47%) | 4 (11%) | 0 | 19 (11%) |
Total post-LT | 106 (90%) | 11 (9%) | 1 (1%) | 124 (89%) | 15 (11%) | 1(1%) |
The subjects in the white cells did not experience any change in their posttransplant frailty category based on the SCA. The subjects in the dark, grey-shaded cells experienced improvement in their frailty category at 3 and/or 6 mo after LT. The subjects in the light, grey-shaded cells experienced worsening in their frailty category at 3 and/or 6 mo after LT.
aAdapted from Lai et al.7
bN (%).
LT, liver transplantation; SCA, Subjective Clinician Assessment.